Peter Kalivas to Alcoholism
This is a "connection" page, showing publications Peter Kalivas has written about Alcoholism.
Connection Strength
1.232
-
N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
Score: 0.373
-
A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
Score: 0.297
-
Last call for adenosine transporters. Nat Neurosci. 2004 Aug; 7(8):795-6.
Score: 0.127
-
Chronic ethanol consumption by C57BL/6 mice promotes tolerance to its interoceptive cues and increases extracellular dopamine, an effect blocked by naltrexone. Alcohol Clin Exp Res. 2003 Dec; 27(12):1892-900.
Score: 0.121
-
Predisposition to addiction: pharmacokinetics, pharmacodynamics, and brain circuitry. Am J Psychiatry. 2003 Jan; 160(1):1-2.
Score: 0.114
-
N-acetylcysteine improves impulse control and attenuates relapse-like alcohol intake in long-term drinking rats. Behav Brain Res. 2023 01 05; 436:114089.
Score: 0.111
-
Brain region-specific gene expression changes after chronic intermittent ethanol exposure and early withdrawal in C57BL/6J mice. Addict Biol. 2012 Mar; 17(2):351-64.
Score: 0.052
-
Development of an alcohol deprivation and escalation effect in C57BL/6J mice. Alcohol Clin Exp Res. 2006 Dec; 30(12):2017-25.
Score: 0.037